LEVY Health, a San Francisco, CA-based innovator in the field of reproductive health technology, raised $4.5M in funding.
The round was led by XYZ Venture Capital, with participation from Atlantic Labs and Possible Ventures.
The company intends to use the funds to integrate its virtual care pathways, which reduce time to treatment from years to weeks, with electronic medical record software, and acceerate growth across women’s health and reproductive care, with solutions for fertility clinics, fertility benefit providers, laboratories, and biopharma companies.
Founded in 2021 by CEO Caroline Mitterdorfer, CPO Silvia Hecher, and Dr. Theresa Vilsmaier, LEVY Health provides clinical decision support based on medical guidelines, clinical studies, and lab data. Its software combines health information with lab results, defining virtual care pathways for patients. Patients and providers benefit from dynamic medical history intake, automated lab orders and interpretation of results, patient triaging to lower and higher complexity treatments, patient education, and direct virtual care.
The software supports 152 diagnoses and provides treatment recommendations in line with ASRM, ESHRE, and ACOG standards, ensuring accurate diagnoses in weeks instead of years.
Clients include industry leaders such as fertility, family building, and women’s health benefits provider, Progyny, US fertility clinic groups Boston IVF and Texas Fertility Center, the Mexican fertility group Fertilidad Integral, as well as the US-based egg donation agency, Everie.
FinSMEs
10/10/2024